← All indications
Bronchiectasis
Persistent abnormal dilatation of the bronchi.
Subtype terms (1)
More specific conditions that are subtypes of Bronchiectasis in the MeSH hierarchy.
- Kartagener Syndrome
7 drugs approved
Drugs by status
Approved for this indication (2)
Phase 4 trials (35)
- levofloxacin
- metronidazole
- propofol
- vitamin d3
- fluticasone
- oxytocin
- theophylline
- petrolatum, white
- tobramycin
- carbetocin
- ceftolozane
- alpha-1 antitrypsin
- ergonovine
- human factor ix complex (prothrombin complex concentrate)
- piperacillin
- atorvastatin
- formoterol
- remimazolam
- immune globulin (human)
- sitafloxacin
- ciprofloxacin
- gentamicin
- azithromycin
- budesonide
- tiotropium
- meropenem
- misoprostol
- beta-alanine
- blood plasma
- sodium chloride
- +5 more
Phase 3 trials (18)
Phase 2 trials (22)
Phase 1 trials (15)
Other trials (34)
- vitamin e
- procaine benzylpenicillin
- beta-hydroxyisovaleric acid
- clavulanate
- fenoterol
- epiceram
- icosapent ethyl
- ipratropium
- whey protein
- krill oil
- mepolizumab
- metamizole
- vitamin c
- human milk
- cow milk
- flumazenil
- procalcitonin
- rocuronium
- collagen
- cellulose
- ashwagandha extract
- albuterol
- oxygen
- moxifloxacin
- ergocalciferol
- erythromycin
- fish oil
- crotalidae antivenin polyvalent (equine)
- vitamin k2
- ketone monoester
- +4 more
Organizations
Organization Involved with Phase 4 Indications (7)
Organization Involved with Phase 3 Indications (35)
- Gilead Sciences
- Grifols
- Zambon
- Novartis
- Aradigm Corporation
- Bayer
- Chiesi
- Neovii Biotech
- Syntara
- Telethon Kids Institute
- University of Pennsylvania
- Ain Shams University
- University of London
- Georgetown University
- Henan University of Traditional Chinese Medicine
- Monash University
- Nanjing Medical University
- Oregon Health and Science University
- Queen's University, Belfast
- Capital Medical University
- Peking University
- Prince of Songkla University
- Zhejiang University
- Tsinghua University
- The Alfred Hospital
- University of Queensland
- RedHill Biopharma
- Pennsylvania State University
- Insmed, Inc.
- Washington University in St. Louis
- +5 more
Organization Involved with Phase 2 Indications (18)
- AstraZeneca
- Polyphor Ltd.
- Regend Therapeutics
- Pulmocide Ltd
- Seoul National University
- University of Dundee
- University of Groningen
- University of Milan
- Papworth Hospital NHS Foundation Trust
- Moscow State University
- Government of Russia
- The University of Hong Kong
- University of Sao Paulo
- University of Barcelona
- European Commission
- Queen Elizabeth Hospital NHS Foundation Trust
- University of Antwerp
- People's Liberation Army of China
Organization Involved with Phase 1 Indications (17)
- CSL Behring
- Ansun Biopharma, Inc.
- GlaxoSmithKline
- Boehringer Ingelheim
- Savara Inc.
- National Institutes of Health (NIH)
- National Institute of Allergy and Infectious Diseases (NIAID)
- Lakehead University
- University of Miami
- Assiut University
- Celerion
- SGS Life Sciences
- Jiao Tong University
- University of Western Ontario
- Eurofins
- STRAGEN
- Northern Ontario School of Medicine
Organization Involved with Other Experimental Indications (11)